Drug Trial Radar · NCT07625644
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
550
Planned (sponsor's estimate)
Start
Aug 4, 2026
Primary completion
Jan 2030
Study completion Jun 2031
Sponsor
- Lead sponsor
- SystImmune Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the efficacy and safety of BL-M14D1 in combination with Atezolizumab compared to Standard-of-Care Therapy in adult participants with previously untreated extensive-stage small cell lung cancer (ES-SCLC).
Conditions
- Small Cell Lung Cancer Extensive Stage
- Small-cell Lung Cancer
- Small Cell Carcinoma
- Sclc
- SCLC,Extensive Stage
- Lung Cancer
- Lung Cancer Metastatic
- Lung Cancer Stage IV
Interventions
BL-M14D1 and AtezolizumabDrug
BL-M14D1 administered in combination with atezolizumab. BL-M14D1 will be given intravenously at the protocol-specified dose and schedule. Atezolizumab will be administered intravenously according to the approved dosing regimen.
Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and LurbinectedinDrug
Carboplatin and etoposide will be administered intravenously in combination with atezolizumab for induction therapy, followed by maintenance treatment with atezolizumab with or without lurbinectedin per protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) per Blinded Independent Central Review (BICR)Time frame: Up to approximately 2 years
Locations
84 sites in 16 countries. Site status is shown where the registry gives one.
Highlands Oncology Group
Springdale, Arkansas · Recruiting
OPN Healthcare
Glendale, California · Recruiting
MemorialCare Todd Cancer Institute
Long Beach, California · Recruiting
Valkyrie Clinical Trials
Los Angeles, California · Recruiting
Total Health and Research Center
Miami, Florida · Recruiting
Astera Cancer Care
East Brunswick, New Jersey · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
One Clinical Research
Nedlands, Australia · Not yet recruiting
Canberra Hospital
Garran, Australian Capital Territory, Australia · Not yet recruiting
Tasman Oncology
Southport, Queensland, Australia · Not yet recruiting
Flinders Medical Centre
Bedford Park, South Australia, Australia · Not yet recruiting
MHAT Dr. Tota Venkova
Gabrovo, Bulgaria · Not yet recruiting
MHAT Heart and Brain
Pleven, Bulgaria · Not yet recruiting
Medical Centre FutureMeds
Plovdiv, Bulgaria · Not yet recruiting
Complex Oncology Center
Plovdiv, Bulgaria · Not yet recruiting
MHAT Pulmed
Plovdiv, Bulgaria · Not yet recruiting
UMHAT Sveti Ivan Rilski
Sofia, Bulgaria · Suspended
MHAT Serdikamed
Sofia, Bulgaria · Not yet recruiting
Arthur Child Cancer Centre
Calgary, Alberta, Canada · Not yet recruiting
University of Sherbrooke
Greenfield Park, Quebec, Canada · Not yet recruiting
Nemocnice České Budějovice, a.s.
České Budějovice, Czechia · Not yet recruiting
Nemocnice Agel Vítkovice
Ostrava, Czechia · Not yet recruiting
Fakultní nemocnice Ostrava (FN Ostrava)
Ostrava-Poruba, Czechia · Not yet recruiting
General University Hospital in Prague
Prague, Czechia · Not yet recruiting
Organization Centre Hospitalier Intercommunal de Creteil (CHIC) - Centre de Recherche Clinique (CRC) (Clinical Research Center)
Créteil, France · Not yet recruiting
CLB - Centre Léon Bérard
Lyon, France · Not yet recruiting
IPC - lnstitut Paoli-Calmettes
Marseille, France · Not yet recruiting
Universite Pierre et Marie Curie (UPMC) - Center de Recherche des Cordeliers (CRC)
Paris, France · Not yet recruiting
ICO - L'Institut de Cancérologie de L'Ouest
Saint-Herblain, France · Not yet recruiting
Gustave Roussy
Villejuif, France · Not yet recruiting
LTD High Technology Hospital Medcenter
Tbilisi, Georgia · Recruiting
Ltd New Hospitals
Tbilisi, Georgia · Recruiting
Pineo Medical Ecosystem LtD
Tbilisi, Georgia · Recruiting
LLC Todua Clinic
Tbilisi, Georgia · Recruiting
The First Medical Clinic LLC
Tbilisi, Georgia · Recruiting
Caucasus Medical Centre
Tbilisi, Georgia · Recruiting
Lungenklinik/Lungenkrebszentrum Köln-Merheim
Cologne, Germany · Not yet recruiting
KEM | Evangelische Kliniken Essen Mitte gGmbH
Essen, Germany · Not yet recruiting
Krankenhaus Martha-Maria Halle-Dölau
Halle, Germany · Not yet recruiting
Henry Dunant Hospital Center
Athens, Greece · Not yet recruiting
Showing 40 of 84 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.